Revitope is an early stage biotechnology company focused on developing the next-generation of T cell redirecting biologics.
Immune-based therapies are redefining how cancer is treated as clinical studies demonstrate unprecedented deep and durable responses in multiple cancers. In particular redirecting T cells to tumors is a successful strategy for immunotherapy of liquid tumors. However, unleashing a potent immune response...
Revitope is an early stage biotechnology company focused on developing the next-generation of T cell redirecting biologics.
Immune-based therapies are redefining how cancer is treated as clinical studies demonstrate unprecedented deep and durable responses in multiple cancers. In particular redirecting T cells to tumors is a successful strategy for immunotherapy of liquid tumors. However, unleashing a potent immune response that is entirely focused on the tumor continues to be elusive.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.